Latest Biotech News

Eli Lilly agreed to acquire three vaccine developers—Curevo, LimmaTech Biologics, and Vaccine Company—in coordinated transactions totaling up to nearly $3.8 billion. The moves broaden Lilly’s...

Cardiovascular biotech Kardigan filed for a Nasdaq initial public offering to fund development of a phase 2b/3 cardiac myosin activator, danicamtiv, plus additional late-stage opportunities. The...

Researchers unveiled a machine learning system designed to deliver just-in-time, risk-stratified sepsis evaluations inside neonatal intensive care units. The system targets earlier recognition...

A research team developed cryopreservable dopaminergic progenitors derived from human induced pluripotent stem cells and reported early functional restoration in Parkinsonian rat models after...

Researchers reported that platinum–antibody conjugates can enhance tumor recognition by the immune system, aiming to address a central limitation of immune checkpoint inhibitors: only a subset of...

Lund University researchers developed a blood test aimed at identifying early indicators of breast cancer recurrence by detecting circulating tumor DNA fragments before conventional imaging or...

A set of reports highlighted incremental but operationally important improvements to care delivery and monitoring. In women’s health, Aspira Women’s Health inked a deal with Cleveland Clinic to...

The FDA granted accelerated approval to Beqalzi (sonrotoclax), marking the first BCL2 inhibitor specifically approved for relapsed or refractory mantle cell lymphoma after at least two prior...

Eli Lilly agreed to acquire three vaccine developers in deals worth up to nearly $4 billion, positioning the company to expand beyond its core cardiometabolic franchise into infectious-disease...

Eli Lilly reported additional early Phase 1b results for VERVE-102, a one-time PCSK9 base-editing therapy acquired from Verve Therapeutics. In the company’s update, a single infusion reduced...

Outlook Therapeutics said the FDA reversed course on its reformulated Avastin version for wet age-related macular degeneration (AMD) after three prior rejections dating back to 2023. The company...

The FDA granted accelerated approval to Beqalzi (sonrotoclax), the first BCL2 inhibitor specifically for relapsed or refractory mantle cell lymphoma (MCL) after at least two prior lines of...

Researchers unveiled an AI system intended to deliver “just-in-time,” risk-stratified evaluations of sepsis in neonatal intensive care units (NICUs). The approach is designed to support earlier...

Arizona State University researchers developed a urine-based diagnostic screening tool designed to identify autism spectrum disorder (ASD) biochemical signatures in children as young as two years...

A clinical trial led by researchers at Dana-Farber Cancer Institute tested a vitamin D receptor (VDR) modulation strategy intended to alter the tumor microenvironment in pancreatic cancer. The...

University of California San Diego researchers unveiled MutationProjector, an AI-enabled tumor genome foundation model designed to map mutational co-dependencies and predict therapy response. The...

Eurobio Scientific signed a distribution partnership to commercialize two Canhelp Genomics molecular oncology assays across the UK, France, Germany, Austria, Switzerland, and the Benelux. The...

Protuoso Biosciences raised $9.5 million in a seed round to build a hub-and-spoke antibody developer model. The funding positions the company to support antibody discovery and development by...

Eli Lilly has agreed to buy three vaccine developers in coordinated deals totaling up to nearly $4 billion, extending the company’s push to prevent disease rather than just treat downstream...

Eli Lilly reported early trial data for VERVE-102, its PCSK9 base-editing program acquired via the Verve Therapeutics buyout, showing a single infusion can reduce LDL cholesterol by as much as 62%...